Scientific Advisory Board
Dr. Walter Maksymowych, M.D., F.R.C.P. (C)
Dr. Maksymowych is a Professor in the Department of Medicine, Division of Rheumatology at the University of Alberta, Canada. He is also a Senior Scholar of the Alberta Heritage Foundation for Medical Research, a member of the Canadian Arthritis Network Centres of Excellence, a member of the Assessments in Ankylosing Spondylitis Working Group, and Scientific Chair of the Rheumatoid Arthritis and Pharmacovigilance Program and Outcomes Research in Therapeutics (RAPPORT) committee.
He has served on the Task Force for the FDA Industry Guidance Document for Clinical Trials in Ankylosing Spondylitis and is the Chair of the American College of Rheumatology Spondyloarthropathy Study Group. He is currently the Scientific Chair of the Canadian Rheumatology Association and the Canadian representative to the Clinical Immunology/Rheumatology Expert Advisory Panel for the United States Pharmacopeia.
Dr. Maksymowych graduated from the University of Manchester School of Medicine, United Kingdom, in 1981 and completed his postgraduate training at the University of Alberta and the Children’s Hospital Medical Center Cincinnati Ohio. He holds Fellowships in the Royal College of Physicians of Canada, the American College of Physicians, and the Royal College of Physicians of the UK. He has authored over seventy peer reviewed papers as well as numerous abstracts and book chapters, and has been invited to speak at both national and international meetings. His primary research interests are ankylosing spondylitis and other sero-negative spondyloarthropathies, rheumatoid arthritis, and the anti-inflammatory and immunomodulatory actions of bisphosphonates.